Somatic TET2 mutations in cardiac remodeling
Somatic TET2 mutations in cardiac remodeling
批准号:
9670519
负责人:
KENNETH WALSH
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-15 至 2021-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The accumulation of somatic DNA mutations over time is a hallmark of aging in many tissues. However, the
causal role of somatic mutations in age-associated disorders other than cancer is a matter of debate, and
remains unexplored in the setting of cardiovascular disease (CVD), the leading cause of death in elderly
individuals. Recent large exome sequencing studies in humans have shown that aging is inevitably associated
with an increased frequency of somatic mutations in the hematopoietic system, which provide a competitive
growth advantage to the mutant cell and thus allow its clonal expansion (clonal hematopoiesis). Unexpectedly,
these somatic mutations were associated with a higher rate of cardiovascular-related deaths,
suggesting a previously unrecognized link between somatic
mutations in bone marrow-derived cells
and CVD
. However, whether there is a causal connection between these somatic mutations and CVD remains
unclear and the potential underlying mechanisms are completely unknown, and this is the scientific premise of
the proposed research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clonal hematopoiesis and severity of COVID-19 disease
-
批准号:10196497
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2021
-
负责人:KENNETH WALSH
-
依托单位:
Clonal hematopoiesis and severity of COVID-19 disease
-
批准号:10413986
-
项目类别:
-
资助金额:$12.02万
-
财政年份:2021
-
负责人:KENNETH WALSH
-
依托单位:
Mosaic loss of Y chromosome in blood and heart failure
-
批准号:10277645
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2021
-
负责人:KENNETH WALSH
-
依托单位:
Mosaic loss of Y chromosome in blood and heart failure
-
批准号:10714372
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2021
-
负责人:KENNETH WALSH
-
依托单位:
Mosaic loss of Y chromosome in blood and heart failure
-
批准号:10646348
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2021
-
负责人:KENNETH WALSH
-
依托单位:
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
-
批准号:10394732
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:KENNETH WALSH
-
依托单位:
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
-
批准号:10172973
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:KENNETH WALSH
-
依托单位:
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
-
批准号:10614493
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:KENNETH WALSH
-
依托单位:
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease
-
批准号:9900053
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2019
-
负责人:KENNETH WALSH
-
依托单位:
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease
-
批准号:10378063
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2019
-
负责人:KENNETH WALSH
-
依托单位:
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity
-
批准号:10390471
-
项目类别:
-
资助金额:$53.48万
-
财政年份:2019
-
负责人:KENNETH WALSH
-
依托单位:
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease
-
批准号:10161815
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2019
-
负责人:KENNETH WALSH
-
依托单位:
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity
-
批准号:9898439
-
项目类别:
-
资助金额:$53.48万
-
财政年份:2019
-
负责人:KENNETH WALSH
-
依托单位:
Somatic TET2 mutations in cardiac remodeling
-
批准号:9364237
-
项目类别:
-
资助金额:$53.69万
-
财政年份:2017
-
负责人:KENNETH WALSH
-
依托单位:
Somatic TET2 mutations in cardiac remodeling
-
批准号:9764464
-
项目类别:
-
资助金额:$63.88万
-
财政年份:2017
-
负责人:KENNETH WALSH
-
依托单位:
Myokine Control of Hepatic Steatosis
-
批准号:9181162
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2016
-
负责人:KENNETH WALSH
-
依托单位:
Inflammatory Pathways in Aortic Aneurysms
-
批准号:9468404
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2016
-
负责人:KENNETH WALSH
-
依托单位:
Myokine Control of Hepatic Steatosis
-
批准号:9346603
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2016
-
负责人:KENNETH WALSH
-
依托单位:
Inflammatory Wnt signaling in ischemic myocardium
-
批准号:9034132
-
项目类别:
-
资助金额:$52.95万
-
财政年份:2016
-
负责人:KENNETH WALSH
-
依托单位:
Inflammatory Wnt signaling in ischemic myocardium
-
批准号:9198056
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2016
-
负责人:KENNETH WALSH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
基于肌成纤维细胞成脂分化研究DNA双加氧酶TET2促进肺纤维化消退的作用及潜在机制
-
批准号:2026JJ81678
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小红
-
依托单位:
TET2下调介导ANGPT1增强子高甲基化在烟雾病术后侧支血管形成中的作用与机制研究
-
批准号:JCZRQNB202600261
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
TET2去甲基化上调CAV1表达介导PGR泛素化降解在妊娠期显性糖尿病并发子痫前期蜕膜化障碍中的作用及干预研究
-
批准号:JCZRLH202600862
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
高糖促子痫前期新机制:TET2/UQCRC1/mtROS途径诱发滋养层细胞铁死亡
-
批准号:2026JJ81903
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:何璐
-
依托单位:
TET2介导的DNA羟甲基化修饰在糖尿病视网膜炎症反应中表观遗传机制研究
-
批准号:2026JJ80304
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈弥
-
依托单位:
肠上皮细胞TET2/AHR/NLRP3轴经“脑肠通讯”激活mPFC小胶质细胞导致抑郁样行为的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:夏美玲
-
依托单位:
基于TET2介导表观遗传修饰探讨SGLT2i
延缓胰岛β细胞应激性衰老的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:尹亮
-
依托单位:
低剪切应力促As新机制:负性调控TET2/NUR77/NDUFB9途径诱发血管内皮细胞焦亡
-
批准号:2025JJ70436
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈金娜
-
依托单位:
UDCA/LDHA/TET2通路调控血管平滑肌细胞表型转化在心脏移植物血管病变中的作用及机制研究
-
批准号:JCZRYB202500118
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: